| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
13,252 |
12,248 |
$777K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,500 |
1,490 |
$164K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,469 |
1,461 |
$145K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,081 |
1,069 |
$108K |
| 99051 |
|
3,287 |
3,236 |
$85K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
838 |
827 |
$85K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,131 |
1,090 |
$78K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,089 |
3,033 |
$42K |
| 87428 |
|
1,262 |
1,237 |
$41K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
712 |
701 |
$28K |
| 92551 |
|
3,129 |
3,100 |
$15K |
| 99173 |
|
3,128 |
3,100 |
$15K |
| G0009 |
Administration of pneumococcal vaccine |
421 |
421 |
$5K |
| G0008 |
Administration of influenza virus vaccine |
358 |
348 |
$4K |
| 96161 |
|
769 |
765 |
$3K |
| 99072 |
|
363 |
354 |
$3K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
152 |
150 |
$2K |
| 90688 |
|
274 |
201 |
$2K |
| 90670 |
|
557 |
524 |
$2K |
| 90698 |
|
350 |
311 |
$2K |
| 90749 |
|
89 |
89 |
$1K |
| 96127 |
|
1,098 |
1,083 |
$968.78 |
| 90633 |
|
223 |
192 |
$866.25 |
| 90680 |
|
330 |
313 |
$820.05 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
787 |
772 |
$783.26 |
| 90651 |
|
169 |
159 |
$762.30 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
16 |
15 |
$645.60 |
| 96160 |
|
1,276 |
1,257 |
$579.69 |
| 90686 |
|
185 |
185 |
$485.10 |
| 90744 |
|
91 |
85 |
$415.80 |
| 90734 |
|
46 |
39 |
$369.60 |
| 81002 |
|
80 |
79 |
$349.97 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
12 |
12 |
$324.92 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
31 |
30 |
$308.78 |
| 99188 |
|
12 |
12 |
$249.48 |
| 90677 |
|
182 |
171 |
$210.00 |
| 90710 |
|
28 |
28 |
$173.25 |
| 90620 |
|
67 |
67 |
$127.05 |
| 94760 |
|
25 |
25 |
$64.59 |
| 90697 |
|
175 |
163 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
363 |
359 |
$0.00 |
| 90619 |
|
87 |
86 |
$0.00 |
| 83655 |
|
141 |
139 |
$0.00 |
| G9920 |
Screening performed and negative |
562 |
561 |
$0.00 |
| 80061 |
Lipid panel |
125 |
124 |
$0.00 |
| 90715 |
|
40 |
40 |
$0.00 |
| G9919 |
Screening performed and positive and provision of recommendations |
47 |
47 |
$0.00 |
| 90661 |
|
57 |
57 |
$0.00 |